Interim Financial Statements
2017Find out more
Malin Corporation plc (ISE:MLC, “Malin”) is an Irish incorporated public limited company whose head office is in Dublin, Ireland with a subsidiary office in Cambridge, United Kingdom.
Malin’s purpose is to create shareholder value through selective long-term application of capital and operational expertise to innovative private businesses in the life sciences industry. Through its operational involvement, Malin works with its investee companies to enable them to reach the full potential of their value proposition.
December 11, 2017Immunocore’s IMCgp100 Receives Promising Innovative Medicine (PIM) Designation Under UK Early Access to Medicines Scheme (EAMS) for the Treatment of Patients with Uveal Melanoma
December 5, 2017Poseida Therapeutics Presents Preclinical Solid Tumor Data for P-PSMA-101 at the American Association for Cancer Research Prostate Cancer Meeting